Cycling, doping & the importance of due process: A review of the Karl Murray caseAni Ghazikhanian
In a decision1 dated 13 October 2017, a Panel from Sports Tribunal of New Zealand found cyclist Karl Murray liable for committing an anti-doping rule violation. Murray was competing in the Tour of Northland when he tested positive for Clenbuterol2 in a sample provided on 18 March 2017.
This article reviews the Tribunal’s decision, looking specifically at:
To continue reading or watching login or register here
Already a member? Sign in
Get access to all of the expert analysis and commentary at LawInSport including articles, webinars, conference videos and podcast transcripts. Find out more here.
- Tags: Anti-Doping | Board of Drug Free Sport New Zealand | Cycling | New Zealand | Prohibited List | WADA Code 2015 | WADA International Standard for Testing and Investigations (ISTI) | World Anti-Doping Agency (WADA)
- U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for Anti-Doping Rule Violation
- Powerful partnership to tackle improper PED prescriptions
- UK Anti-Doping Releases Findings into its Cycling Investigation